Early health technology assessment of magnetic resonance-guided high intensity focused ultrasound ablation for the treatment of early-stage breast cancer.
Floortje M KnuttelSèvrin E M HuijsseTalitha L FeenstraChrit T W MoonenMaurice A A J van den BoschErik BuskensMarcel J W GreuterGeertruida H de BockPublished in: Journal of therapeutic ultrasound (2017)
MR-HIFU ablation is currently not a cost-effective alternative for BCT. MR-HIFU experience is limited, increasing uncertainty of estimations. The potential for cost-effectiveness increases if future research reduces treatment durations and might substantiate equal or improved results.